Golden, Encouse

Publications

Sort by

Co-Author Network

selected publications

Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference. Oncoimmunology. 2025 Conference Paper GET IT
Spectrum of Findings Seen in Patients With IDH1/2-Mutant Cholangiocarcinoma. International journal of surgical pathology. 2024 Academic Article GET IT
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science immunology. 2023 Review GET IT
Times cited: 23
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell death & disease. 2023 Academic Article GET IT
Times cited: 15
MRI-LINAC: A transformative technology in radiation oncology. Frontiers in oncology. 2023 Review GET IT
Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals. JCI insight. 2021 Academic Article GET IT
Times cited: 17
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva. Pathogens & immunity. 2021 Academic Article GET IT
Times cited: 84
Redistributing Central Target Dose Hot Spots for Hypofractionated Radiosurgery of Large Brain Tumors: A Proof-of-Principle Study. Acta neurochirurgica. Supplement. 2021 Academic Article GET IT
Radiation Therapy and the In Situ Vaccination Approach. International journal of radiation oncology, biology, physics. 2020 Review GET IT
Times cited: 67
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal for immunotherapy of cancer. 2020 Information Resource GET IT
Times cited: 803
Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines. Advances in radiation oncology. 2019 Academic Article GET IT
Times cited: 17
Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nature medicine. 2018 Academic Article GET IT
Times cited: 743
Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 9
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 2016 Academic Article GET IT
Times cited: 690
Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer. Cancer. 2016 Academic Article GET IT
Times cited: 78
Role of Local Radiation Therapy in Cancer Immunotherapy. JAMA oncology. 2015 Review GET IT
Times cited: 590
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (New York, N.Y.). 2015 Academic Article GET IT
Times cited: 2772
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. The Lancet. Oncology. 2015 Academic Article GET IT
Times cited: 568
Radiotherapy for extensive stage small-cell lung cancer. Lancet (London, England). 2015 Letter GET IT
Times cited: 2
Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals. Neurosurgical focus. 2015 Academic Article GET IT
Times cited: 20
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurgical focus. 2015 Academic Article GET IT
Times cited: 136
Radiation therapy and immunotherapy: growing pains. International journal of radiation oncology, biology, physics. 2015 Editorial Article GET IT
Times cited: 26
Radiotherapy and immunogenic cell death. Seminars in radiation oncology. 2015 Review GET IT
Times cited: 360
Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurgical focus. 2014 Academic Article GET IT
Times cited: 148
Taxanes as radiosensitizers. Anti-cancer drugs. 2014 Review GET IT
Times cited: 30
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 473
Is tumor (R)ejection by the immune system the "5th R" of radiobiology?. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 53
An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. 2013 GET IT
Times cited: 593
The convergence of radiation and immunogenic cell death signaling pathways. Frontiers in oncology. 2012 Academic Article GET IT
Times cited: 238
Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer letters. 2012 Academic Article GET IT
Times cited: 105
Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors. Cancer letters. 2012 Academic Article GET IT
Times cited: 55
Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. Cancer letters. 2011 Academic Article GET IT
Times cited: 102
Antiangiogenic activities of 2,5-dimethyl-celecoxib on the tumor vasculature. Molecular cancer therapeutics. 2010 Academic Article GET IT
Times cited: 25
Glioma-associated endothelial cells are chemoresistant to temozolomide. Journal of neuro-oncology. 2009 Academic Article GET IT
Times cited: 43
Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. Cancer letters. 2009 Academic Article GET IT
Times cited: 45
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 2009 Academic Article GET IT
Times cited: 256
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer research. 2008 Academic Article GET IT
Times cited: 118

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Dynamics of Immune Response in Irradiated Rectal Cancer awarded by National Cancer Institute Co-Principal Investigator 2022 - 2027

more ...

less ...

Background

education and training

M.D., Ph.D., University of Southern California, Keck School of Medicine 2009
B.S., University of Southern California 2001

Contact

full name

Encouse Golden

primary email

eng2003@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Encouse Golden Associate Professor of Clinical Radiation Oncology

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage